Latest Breaking News On - Motrin oral suspension - Page 1 : comparemela.com

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Children s Motrin Oral Suspension, 100 mg/mL, of Johnson & Johnson Consumer Inc. Strides is focusing on building a private label business in the US by leveraging its portfolio of products across soft gels, tablets, capsules, topicals, powders and oral solutions. Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) further strengthens company s private label portfolio for the US market. According to IRi data, the US market for Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) is

Johnson consumer incUnited states food drug administrationStrides pharma scienceStrides pharma globalIbuprofen oral suspensionUnited states foodDrug administrationReference listed drugMotrin oral suspensionJohnson consumerCapital marketNon steroidal anti inflammatory drugsHealth sciencesStrides pharma science limitedJohnson amp consumer incUnited states food amp drug administration